Karyopharm Therapeutics Inc
KPTI
Market Cap$51.5M
Close$
$1.36
77.4% downside
Current Fair Value
77.4% downsideOvervalued by 77.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $51.50 Million |
|---|---|
| Enterprise Value | $183.55 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.63 |
| Beta | 0.34 |
| Outstanding Shares | 8,392,066 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.66 |
|---|---|
| PEG | 9.36 |
| Price to Sales | 0.38 |
| Price to Book Ratio | -0.26 |
| Enterprise Value to Revenue | 1.32 |
| Enterprise Value to EBIT | -1.46 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 1.06 |
| Debt to Equity | -1.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Karyopharm Therapeutics Inc
CEO: Michael Kauffman